Anker
Georg Anker, Kundl AT
Patent application number | Description | Published |
---|---|---|
20150224102 | Stable pharmaceutical composition containing 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(- 4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof - The present invention relates to a stable pharmaceutical composition comprising amorphous or crystalline linagliptin or a pharmaceutically acceptable salt of linagliptin, mannitol, copovidone, and magnesium stearate, processes for preparing the stable pharmaceutical composition, and a container comprising the stable pharmaceutical composition. | 08-13-2015 |
Jeffrey Anker, Greenville, SC US
Patent application number | Description | Published |
---|---|---|
20140046191 | Luminescent Tension-Indicating Orthopedic Strain Gauges for Non-Invasive Measurements Through Tissue - Strain gauges that can provide information with regard to the state of implantable devices are described. The strain gauges can exhibit luminescence that is detectable through living tissue, and the detectable luminescent emission can vary according to the strain applied to the gauge. A change in residual strain of the device can signify a loss of mechanical integrity and/or loosening of the implant, and this can be non-invasively detected either by simple visual detection of the luminescent emission or through examination of the emission with a detector such as a spectrometer or a camera. | 02-13-2014 |
Jeffrey Anker, Clemson, SC US
Patent application number | Description | Published |
---|---|---|
20150362500 | X-ray Excited Optical Materials and Methods for High Resolution Chemical Imaging - X-ray/optical imaging materials are described and techniques as may be used for sensitive and high spatial resolution chemical and biophysical imaging in tissue. The technique uses high spatial resolution deeply penetrating X-rays to excite scintillators which convert the energy to a different frequency, e.g., visible light frequencies. The emitted spectrum is then modulated by a chemical indicating element such as an indicator dye held in optical communication with the scintillators in order to detect specific concentrations in the local area. The materials can include a magnetic element in conjunction with the scintillator and chemical indicating element. The materials can incorporate a biologically active agent for delivery. | 12-17-2015 |
John Anker, Petten NL
Patent application number | Description | Published |
---|---|---|
20150357499 | METHOD OF PROVIDING A BORON DOPED REGION IN A SUBSTRATE AND A SOLAR CELL USING SUCH A SUBSTRATE - Method of providing a boron doped region ( | 12-10-2015 |
Johnny Anker, Anna Paulowna NL
Patent application number | Description | Published |
---|---|---|
20090270352 | Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal - The present invention provides a novel crystalline form of Tenofovir disoproxil fumarate (Tenofovir DF), designated Co-crystal TDFA 2:1, methods for the preparation thereof and its use in pharmaceutical applications, in particular in anti-HIV medicaments. The crystalline form TDFA 2:1 can be used in combination with other anti-HIV medicaments such as Efavirenz, Emtricitabine, Ritonavir and/or TMC114. | 10-29-2009 |
Johnny Anker, Paulowna NL
Patent application number | Description | Published |
---|---|---|
20090176983 | Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal - The present invention provides a novel crystalline form of Tenofovir disoproxil fumarate (Tenofovir DF), designated Co-crystal TDFA 2:1, methods for the preparation thereof and its use in pharmaceutical applications, in particular in anti-HIV medicaments. The crystalline form TDFA 2:1 can be used in combination with other anti-HIV medicaments such as Efavirenz, Emtricitabine, Ritonavir and/or TMC114. | 07-09-2009 |
Luis E. Anker US
Patent application number | Description | Published |
---|---|---|
20120014102 | VERSATILE LIGHTING UNITS - Systems and methods which provide a versatile lighting module which may be utilized alone or in combination with other lighting modules to provide any number of lighting unit configurations are shown. Lighting modules of embodiments herein are adapted to facilitate electrical connection, whether to one or more power supply and/or to one or more other lighting module, along any portion of the entire periphery of the lighting module. Accordingly, lighting modules may be coupled together in any orientation, geometry, and topology to cooperate as a light source having various desired characteristics according to embodiments herein. | 01-19-2012 |
20120294008 | VERSATILE LIGHTING UNITS - Systems and methods which provide a versatile lighting module which may be utilized alone or in combination with other lighting modules to provide any number of lighting unit configurations are shown. Lighting modules of embodiments herein are adapted to facilitate electrical connection, whether to one or more power supply and/or to one or more other lighting module, along any portion of the entire periphery of the lighting module. Accordingly, lighting modules may be coupled together in any orientation, geometry, and topology to cooperate as a light source having various desired characteristics according to embodiments herein. | 11-22-2012 |
Marc David Anker, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20130171599 | System and Method for Reliably Coordinating Musculoskeletal and Cardiovascular Hemodynamics - Systems and methods are disclosed to enable a user to favorably coordinate the timing of musculoskeletal movement and skeletal muscle contraction and relaxation with the cardiac pumping cycle in order to improve perfusion of cardiac and peripheral skeletal muscle and other tissues, increase physiological efficiency, decrease myocardial stress, and enhance individual performance, health and safety during rhythmic physical activity. Additionally, systems and methods are disclosed to enable a user to avoid inadvertent unfavorable coordination of musculoskeletal movement and skeletal muscle contractions and relaxation cycles with the cardiac pumping cycle during physical activity. | 07-04-2013 |
Martin Anker, Hisings Kaerra SE
Patent application number | Description | Published |
---|---|---|
20150112032 | Process and Plant for Manufacturing Polyethylene-Silane-Copolymers - The present invention relates to a process for manufacturing polyethylene-silane-copolymer conducted in a plant including at least one compressor unit and at least one reactor downstream of the compressor unit. The process includes the steps of (a) feeding a first feed stream including ethylene into the at least one compressor unit and subsequently to the at least one reactor, and (b1) feeding a second feed stream including at least one silane comonomer to the at least one reactor as front feed and/or (b2) feeding a second feed stream including at least one silane comonomer to the at least one reactor at at least one location along the reactor. | 04-23-2015 |
20150133616 | Process and Plant for Manufacturing Polyethylene-Diene-Copolymers - The present invention provides a process for manufacturing polyethylene-diene-copolymer conducted in a plant including at least one compressor unit, at least one preheater unit downstream of the compressor unit and at least one reactor, in particular a reactor, downstream of the compressor unit and the preheater unit. The process comprising the steps of (a) feeding a first feed stream comprising ethylene into the at least one compressor unit and subsequently into the at least one preheater unit, and (b1) feeding a second feed stream including at least one diene comonomer to the first feed stream leaving the at least preheater unit, and feeding the combined feed streams including ethylene and the at least one diene comonomer to the at least one reactor, and/or (b2) feeding a second feed stream including at least one diene comonomer to the at least one reactor at at least one location along the reactor. | 05-14-2015 |
Poul Leo Anker, Birkerod DK
Patent application number | Description | Published |
---|---|---|
20120330333 | DEVICE FOR REMOVING ACROCHORDONS | 12-27-2012 |
Sam Anker, Coventry, Warwickshire GB
Patent application number | Description | Published |
---|---|---|
20160031287 | RIDE HEIGHT CONTROL SYSTEM AND METHOD - The present invention relates to a control system ( | 02-04-2016 |
Sam Anker, Whitley GB
Patent application number | Description | Published |
---|---|---|
20140067219 | VEHICLE AND METHOD OF CONTROLLING A VEHICLE - In one aspect of the invention there is provided a motor vehicle having: a prime mover; at least first and second groups of one or more wheels; and a driveline to connect the prime mover to the first and second groups of one or more wheels such that the first group of one or more wheels is driven by the prime mover when the driveline is in a first mode of operation and the second group of one or more wheels is additionally driven by the prime mover when the driveline is in a second mode of operation, the driveline including an auxiliary driveline comprising releasable torque transmitting means operable to connect the second group of one or more wheels to the prime mover when the driveline transitions between the first mode and the second mode, wherein when in the first mode the driveline is operable to transition to the second mode responsive to an output of a reactive evaluator and a predictive evaluator, the output of the reactive evaluator being responsive to a determination whether an amount of wheel slip has exceeded a first prescribed threshold, the output of the predictive evaluator being responsive to a determination that one or more conditions in respect of one or more vehicle operating parameters are met when the amount of wheel slip is below the first prescribed threshold. | 03-06-2014 |
Sam Anker, Coventry GB
Patent application number | Description | Published |
---|---|---|
20140350789 | VEHICLE CONTROL SYSTEM AND METHOD FOR CONTROLLING A VEHICLE - A vehicle control system for at least one vehicle subsystem of a vehicle; the vehicle control system comprising a subsystem controller for initiating control of the or each of the vehicle subsystems in a selected one of a plurality of different subsystem control modes, each of which corresponds to one or more different driving conditions for the vehicle. Evaluation means are provided for evaluating one or more driving condition indicators to determine the extent to which each of the subsystem control modes is appropriate and for providing an output to the subsystem controller that is indicative of the control mode which is most appropriate. This may be an evaluation means for calculating the probability that the or each of the subsystem control modes is appropriate. Automatic control means may be operable in an automatic response mode to select an appropriate one of the subsystem control modes in dependence on the output. | 11-27-2014 |
20150203124 | VEHICLE CONTROL SYSTEM AND METHOD - Embodiments of the present invention provide a motor vehicle control system for selecting a driving surface and for controlling a plurality of vehicle subsystems to operate in a plurality of subsystem configuration modes in dependence on the selected driving surface, the system being operable in a manual operating mode in which a user is able to select said driving surface and an automatic operating mode in which the system is operable to select said driving surface automatically; wherein the system is able to be switched between said manual and automatic operating modes by means of a user-operable input device; and wherein when operating in the automatic operating mode and a change from the automatic operating mode to the manual operating mode is made via the user-operable device, the system is configured to select a default subsystem configuration mode. | 07-23-2015 |
20150210290 | VEHICLE CONTROL SYSTEM AND METHOD - Embodiments of the present invention provide a control system for a motor vehicle, the system being operable in an automatic mode selection condition in which the system is configured to select automatically an appropriate system operating mode from a plurality of operating modes whereby the system assumes operation in said system operating mode, the system being further operable to activate an automatic progress control function in which a speed of the vehicle over terrain is controlled automatically by the system, wherein when the system is in the automatic mode selection condition the system is configured to allow the automatic progress control function to be activated only when the system is operating in one of a subset of one or more system operating modes. | 07-30-2015 |
20150217778 | VEHICLE CONTROL SYSTEM AND METHOD - Embodiments of the present invention provide a motor vehicle control system for selecting and/or determining a driving surface and for controlling a plurality of vehicle subsystems to operate in a plurality of subsystem control modes in dependence on the selected/determined driving surface, the system being operable in a manual control mode selection condition in which a user is able to select said driving surface and an automatic control mode selection condition in which the system is configured to select said driving surface automatically, wherein the vehicle control system is provided with a memory arranged to memorise a last selected control mode that was selected prior to vehicle de-activation or key-off when operating in the automatic control mode selection condition, and upon the next subsequent vehicle activation or key-on, the system is configured to continue operating in the memorised control mode and to automatically obtain new data in respect of a driving surface over which the vehicle is moving before allowing a change in control mode to take place. | 08-06-2015 |
20150224989 | VEHICLE CONTROL SYSTEM AND METHOD - Embodiments of the present invention provide a control system for a motor vehicle, the system being operable in an automatic mode selection condition in which the system is configured to select automatically an appropriate system operating mode whereby the system assumes operation in said system operating mode, the system being further configured to allow activation of an automatic progress control function in which a speed of the vehicle over terrain is controlled automatically by the system, wherein when the automatic progress control function is active the system is configured automatically to suspend changes in the selected system operating mode. | 08-13-2015 |
20150246590 | VEHICLE CONTROL SYSTEM AND METHOD - Embodiments of the present invention provide a control system for a motor vehicle, the system being operable in a manual operating mode selection condition in which a user may select a required system operating mode by means of user-operable mode selection input means, and an automatic mode selection condition in which the system is configured to select automatically an appropriate system operating mode, wherein when operating in the manual condition and a change from the manual condition to the automatic condition is made the system is configured to select a prescribed automatic mode selection condition vehicle ride-height independently of the selected operating mode. | 09-03-2015 |
20150298697 | VEHICLE CONTROL SYSTEM AND METHOD - Embodiments of the present invention provide a control system for a motor vehicle, the system being operable in an automatic mode selection condition in which the system is configured to select automatically an appropriate system operating mode and to assume operation in said system operating mode, wherein when operating in the automatic mode selection condition the system is configured to prevent selection of a prescribed one or more operating modes if it is determined that the vehicle is towing a load. | 10-22-2015 |
Stefan Anker, Abingdon GB
Patent application number | Description | Published |
---|---|---|
20140194484 | Method of Treating Cachexia and Sarcopenia - The present invention relates to a method of treating a cachexia and/or sarcopenia with an oral dose of S-pindolol or a pharmaceutical formulation thereof and to an oral formulation for use in said method of treatment. The method and oral formulation comprise administering a total daily dose of 2.5 to 20 mg of S-pindolol or a pharmaceutical formulation comprising the same. | 07-10-2014 |
Stefan Anker, Berlin DE
Patent application number | Description | Published |
---|---|---|
20080269179 | Use of Megestrol Acetate for the Treatment of Obstructive Pulmonary Diseases - The present invention relates to the treatment of patients suffering from pulmonary diseases, in particular from chronic obstructive pulmonary disease (COPD), bronchial asthma, cystic fibrosis and chronic cough in particular as caused by ACE-Inhibitors using megestrol acetate. | 10-30-2008 |
20090197851 | THERAPY AND USE OF COMPOUNDS IN THERAPY - A method of treating, preventing or ameliorating chronic heart failure or acute heart failure in a patient the method comprising administering to the patient an effective amount of: a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule, for example LPS binding protein, BPI, lipoproteins, bile acids or an antibody capable of binding LPS, a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule or bacterium in the gut, for example charcoal, a bile acid or Fuller's earth, an antibacterial agent that is substantially active in the gut, an agent that is able to inhibit the response by a cell to endotoxin (lipopolysaccharide; LPS), an agent that may form a barrier or that otherwise impedes translocation of bacteria or endotoxin (LPS) from the gut into the patient's circulation. A method of treating, preventing or ameliorating endotoxin-mediated immune activation in acute or chronic heart failure in a patient the method comprising administering to the patient an effective amount of: a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule, for example LPS binding protein, BPI, lipoproteins, bile acids or an antibody capable of binding LPS, a compound that is able to bind to an endotoxin (lipopolysaccharide; LPS) molecule or bacterium in the gut, for example charcoal, a bile acid or Fuller's earth, an antibacterial agent that is substantially active in the gut, an agent that is able to inhibit the response by a cell to endotoxin (lipopolysaccharide; LPS), an agent that may form a barrier or that otherwise impedes translocation of bacteria or endotoxin (LPS) from the gut into the patient's circulation. | 08-06-2009 |
20090248101 | METHOD FOR ENHANCING THE PERFORMANCE AND GENERAL CONDITION OF A SUBJECT - The invention concerns the therapy with a cardiac resynchronisation device (CRT) and/or therapy with an automated internal cardiac defibrilator (ICD) for the treatment of subjects without cardiac diseases, in particular patients with any cancer or patients with cachexia due to acute or chronic illness other than cardiac illness, including malignant tumor disease, COPD, chronic renal failure, liver cirrhosis, chronic infections, and/or AIDS. | 10-01-2009 |
20100143953 | DIAGNOSIS AND RISK STRATIFICATION OF CARDIAC INSUFFICIENCY BY MEANS OF NATRIURETIC PEPTIDES FOR NYHA I PATIENTS - The invention relates to a method for the diagnosis, and/or risk stratification, and/or outcome prognosis of cardiac insufficiency for NYHA I patients, wherein a determination of the proANP marker, NT-proANP marker, or fragments or partial peptides thereof is carried out parallel to a determination of BNP, proBNP, and/or NT-proBNP on patients to be examined. | 06-10-2010 |
20100285493 | METHOD FOR DETERMINING AMINO-TERMINAL PROANP IN PATIENTS HAVING A CARDIAC DISEASE OR BEING SUSPECTED OF DEVELOPING OR HAVING A CARDIAC DISEASE - The present invention relates to an in vitro method for medical diagnosis, prognosis and therapy follow-up for patients having a cardiac disease or being suspected of developing or having a cardiac disease comprising the steps of: providing a sample of a patient having a cardiac disease or being suspected of developing or having a cardiac disease, determining amino-terminal proANP or partial peptides thereof having from 12 to 98 amino acids in said sample using at least one antibody that binds specifically to a partial sequence of amino-terminal proANP, attributing the determined amino-terminal proANP level or the level of partial peptides thereof to a clinical picture wherein the attribution is carried out independent of the BMI of the patient. The present invention further concerns a rapid test assay and a kit for conducting the method of the present invention and the use of antibodies suitable for the method and assays according to the present invention. | 11-11-2010 |
20120095070 | PREVENTION AND TREATMENT OF SARCOPENIA - The present invention provides a means for prevention and treatment of sarcopenia by administration of a substance that both reduces the sensibility of beta-adrenergic receptors and of 5-HT1a receptors. (S)-pindolol, (S)-propanol, tertalol, or bopindolol are preferred for this purpose. | 04-19-2012 |
20130143848 | USE OF MEGESTROL ACETATE FOR IMPROVING HEART FUNCTION AND THE TREATMENT OF HEART INSUFFICIENCY - The present invention relates to improving the heart function, the survival and/or the treatment of heart insufficiency using megestrol acetate (Megace®; MA) in patients with heart insufficiency and after a myocardial infarction. | 06-06-2013 |
20130267797 | METHOD FOR ENHANCING THE PERFORMANCE AND GENERAL CONDITION OF A SUBJECT - The invention concerns the therapy with a cardiac resynchronization device (CRT) and/or therapy with an automated internal cardiac defibrillator (ICD) for treating patients with any cancer or patients with cachexia due to acute or chronic illness other than cardiac illness, including malignant tumor disease, COPD, chronic renal failure, liver cirrhosis, chronic infections, and/or AIDS. Areas of application are the life sciences, in particular medicine and medical technology. | 10-10-2013 |
20160022612 | OXPRENOLOL COMPOSITIONS FOR TREATING CANCER - The present invention relates to compositions of S-enantiomer enriched oxprenolol and their use in treating cancer and treating or preventing, in cancer patients, cachexia, body weight loss, lean body mass loss and adipose tissue loss, and improving quality of life and prolonging survival of cancer patients. | 01-28-2016 |
20160022613 | S-ENANTIOMERICALLY ENRICHED COMPOSITIONS OF BETA BLOCKERS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS - The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof. | 01-28-2016 |
Stefan Dietmar Anker, London GB
Patent application number | Description | Published |
---|---|---|
20090023639 | Methods of Treatment - A method of treating weight loss due to underlying disease in a patient, the method comprising administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity. A method of treating weight loss due to underlying disease in a patient the method comprising administering to the patient an effective amount of any one or more of the following: a compound which inhibits the effect of aldosterone such as an aldosterone antagonist; a chymase inhibitor; a cathepsin B inhibitor; a β receptor blocker; an imidazoline receptor antagonist; a centrally acting α receptor antagonist; a peripherally acting α receptor antagonist; a ganglion blocking agent; a drug that has an effect on cardiovascular reflexes and thereby reduces SNS activity such as an opiate; scopolamine; an endothelin receptor antagonist; and a xanthine oxidase inhibitor. The methods are particularly useful in treating cardiac cachexia. | 01-22-2009 |
Tal Anker, Modiin IL
Patent application number | Description | Published |
---|---|---|
20080201772 | Method and Apparatus for Deep Packet Inspection for Network Intrusion Detection - In a method of determining whether a data stream includes unauthorized data, the data stream is analyzed using a hardware filter to detect a presence of one or more of a first set of patterns in the data stream. It is determined whether a packet in the data stream belongs to one of a plurality of data flows to be further inspected based on the analysis of the data stream by the hardware filter. A set of rules is applied to the packet to produce rule match status data if it is determined that the packet belongs to one of the plurality of data flows to be further inspected. The packet is analyzed to determine if the packet includes unauthorized data using software stored on a computer-readable medium and implemented on a processor if the rule match status data indicates that the packet potentially includes unauthorized data. | 08-21-2008 |
20090323383 | COMPARING DATA REPRESENTATIONS TO STORED PATTERNS - A search engine includes a storage module to store a plurality of data patterns, a plurality of busses to receive a plurality of representations of a search word, a selector corresponding to at least one of the plurality of data patterns to select one of the plurality of representations of the search word for comparing to the at least one of the plurality of data patterns, and a logic circuit operatively coupled to the storage module, to the plurality of busses, and to the selector to compare the selected one of the plurality of representations of the search word to the at least one of the plurality of data patterns. | 12-31-2009 |
20130254421 | METHOD AND APPARATUS FOR DEEP PACKET INSPECTION FOR NETWORK INTRUSION DETECTION - A method for processing packets in a network device includes receiving a packet at the network device, identifying a flow with which the packet is associated, and, based at least in part on the identified flow, selectively causing the packet, or a packet descriptor associated with the packet, to bypass at least a first packet processing unit of the network device. | 09-26-2013 |
Tal Anker, Elishema IL
Patent application number | Description | Published |
---|---|---|
20080282246 | COMPILER AIDED TICKET SCHEDULING OF TASKS IN A COMPUTING SYSTEM - A method of scheduling tasks for execution in a computer system includes determining a dynamic worst case execution time for a non-periodic task. The dynamic worst case execution time is based on an actual execution path of the non-periodic task. An available time period is also determined, wherein the available time period is an amount of time available for execution of the non-periodic task. The non-periodic task is scheduled for execution if the dynamic worst case execution time is less than the available time period. | 11-13-2008 |
Willem Anker, Ellerbek DE
Patent application number | Description | Published |
---|---|---|
20090088483 | AQUEOUS SUSPENSIONS OR DISPERSIONS OF INORGANIC PIGMENTS CONTAINING A MIXTURE CONSISTING OF DIALDEHYDES AND FORMALDEHYDE CLEAVERS - The invention relates to aqueous suspensions or dispersions (slurries) of minerals and/or fillers and/or pigments containing one or more dialdehydes and one or more formaldehyde cleavers, and to the use of mixtures consisting of one or more dialdehydes and of one or more formaldehyde cleavers for stabilizing aqueous suspensions or dispersions of minerals and/or fillers and/or pigments (slurries) with regard to infestation or deterioration by microorganisms. | 04-02-2009 |
20130131130 | SYNERGISTIC PRESERVATIVE COMPOSITIONS - A preservative composition comprising: (a) 1,2-Benzisothiazolin-3-one (BIT); (b) 3-Iodo-2-propynyl carbamate (IPBC); and (c) a mixture of 5-Chloro-2-methyl-4-isothiazolin-3-one (CMIT) and 2-Methyl-4-isothiazolm-3-one (MIT). | 05-23-2013 |
20130195947 | BIOCIDE POWDER FORMULATION - A storage stable, free flowing powder concentrate for use in the manufacture of a biocide formulation comprises a t biocide containing an iodopropynyl group and an inert filler, wherein the wt % ratio of biocide: inert filler is from about 1:1 to about 1:100 and the wt % of biocide is not more than 50%. | 08-01-2013 |
William J. Anker, Londonderry, NH US
Patent application number | Description | Published |
---|---|---|
20140118033 | GLITCHLESS CLOCK SWITCHING THAT HANDLES STOPPED CLOCKS - An integrated circuit receives a first and second clock signal and a select signal that selects one of the clock signals. A glitchless switching circuit supplies an output clock signal according to which of the first and second clocks is selected by the select signal. A reset circuit coupled to the glitchless switching circuit responds to a direction of a transition of the select signal and generates a first reset signal in response to a first direction of the transition and generates a second reset signal in response to a second direction of the transition. The reset pulses are supplied respectively to first and second paths in the glitchless switching circuit to reset the state machine formed by the first and second paths in the event one of the input clocks is absent. | 05-01-2014 |
Yaakov Anker, Salit IL
Patent application number | Description | Published |
---|---|---|
20140124438 | WASTEWATER TREATMENT METHOD AND DEVICE - Installation and method for processing wastewater, comprising: a) providing wastewater for processing; b) reducing O2 content of said wastewater by unactivated aerobic digestion; c) subsequently to ‘b’, eliminating substantially all O2 from said wastewater by anaerobic digestion; d) subsequently to ‘c’, transferring said wastewater to a closed photobioreactor; and e) subsequently to ‘d’, maintaining said wastewater in said photobioreactor in conditions favorable for algal photosynthesis, thereby allowing algae to grow in said photobioreactor. A method for growing algae is also disclosed whereby time, density and flow speed are controlled. The photobioreactor may have a conduit with two proportions of different cross sections. | 05-08-2014 |
20140360934 | AERATION OF LIQUID SUITABLE FOR AQUEOUS WASTE TREATMENT - Aerator kit comprising a body defining a fluid-flow channel, and a nozzle insert disposed inside said body as such forming together a venturi aerator which is useful for aerating aqueous waste. The aerator can be used submerged as a part of an aerobic digester, in which gas or air flow into the nozzle inlet while drawing liquid through a peripheral hole in the aerators body and cause mixing. The aerator can be also used as an above ground aerator in which liquid is pumped into the nozzle inlet while drawing air through said peripheral hole. In an another embodiment the aerator could be also used for adding additive to a gas or liquid. | 12-11-2014 |
20150252318 | METHOD AND DEVICE SUITABLE FOR GROWING ALGAE - Disclosed are methods and devices suitable for growing algae. | 09-10-2015 |